Spots Global Cancer Trial Database for HIPEC After Radical Cystectomy for High Risk Bladder Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: HIPEC After Radical Cystectomy for High Risk Bladder Cancer
Official Title: A Pilot Study for Hyperthermic Intraperitoneal Chemotherapy After Radical Cystectomy With Pelvic Lymph Node Dissection for High Risk Invasive Bladder Cancer
Study ID: NCT03514888
Conditions
Interventions
Study Description
Brief Summary: This is a non-randomized, non-blinded, pilot study administering hyperthermic intraperitoneal chemotherapy with Mitomycin-C in 10 men and women with muscle-invasive urothelial carcinoma of the bladder undergoing radical cystectomy with pelvic lymph node dissection who have risk factors for tumor recurrence.
Detailed Description:
Eligibility
Minimum Age: 45 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: Yes
Locations
Weill Cornell Medicine - New York Presbyterian Hospital, New York, New York, United States
Contact Details
Name: Douglas S Scherr, MD
Affiliation: Weill Cornell Medicine - New York Presbyterian Hospital
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
